Patents by Inventor Herbert Graham

Herbert Graham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BOTULINUM TOXIN NEUROTOXIC COMPONENT FOR TREATING JUVENILE CEREBRAL PALSY
    Publication number: 20070224221
    Abstract: The invention provides for the use of a presynaptic neurotoxin (for example a bacterial neurotoxin such as botulinum toxin A) for the manufacture of a medicament for the treatment of cerebral palsy in juvenile patients. The juvenile patients are preferably juveniles of up to 6 years in age.
    Type: Application
    Filed: May 22, 2007
    Publication date: September 27, 2007
    Applicant: ALLERGAN, INC.
    Inventor: HERBERT GRAHAM
  • Botulinum toxin for treating muscle contracture
    Publication number: 20060093624
    Abstract: The invention provides for the use of a botulinum toxin to treat contracture, such as muscle contracture, in patients by transdermal administration of the botulinum toxin.
    Type: Application
    Filed: August 22, 2005
    Publication date: May 4, 2006
    Applicant: Allergan, Inc.
    Inventor: Herbert Graham
  • Botulinum toxin formulations
    Publication number: 20050142150
    Abstract: The invention provides for the use of a presynaptic neurotoxin (for example a bacterial neurotoxin such as botulinum toxin A) for the manufacture of a medicament for the treatment of cerebral palsy in juvenile patients. The juvenile patients are preferably juveniles of up to 6 years in age.
    Type: Application
    Filed: October 29, 2004
    Publication date: June 30, 2005
    Applicant: ALLERGAN, INC.
    Inventor: Herbert Graham
  • Botulinum toxin neurotoxic components formulations
    Publication number: 20050112146
    Abstract: The invention provides for the use of a presynaptic neurotoxin (for example a bacterial neurotoxin such as botulinum toxin A) for the manufacture of a medicament for the treatment of cerebral palsy in juvenile patients. The juvenile patients are preferably juveniles of up to 6 years in age.
    Type: Application
    Filed: October 29, 2004
    Publication date: May 26, 2005
    Applicant: ALLERGAN, INC.
    Inventor: Herbert Graham